Immuno-oncology and the microbiome

The relationship between bacteria and cancer is more and more investigated. We discuss it with Laurence Zitvogel, oncologist at the Institut Gustave Roussy.

Gut microbes could shape the course of multiple sclerosis

According to a recent study, the gut microbiota could determine remittance or pro-inflammatory conditions in multiple sclerosis.

How the microbiome changes in the space environment

Does the space environment affect the composition of the human microbiota? A large study published in Science sheds light on the question.

James Kinross: ‘Gut microbiota plays a fundamental role in the outcome of colorectal surgery’

Bacteria are critical in determining the outcome of surgical procedure. We talked about this with James Kinross from the Imperial College London.

Imbalance of Staphylococcus bacteria could be responsible for skin damage and inflammation

Scientists have traced how the interplay of different species of Staphylococcus bacteria on the skin could influence the severity of skin eczema.

A better mouse model for inflammatory bowel disease

Researchers at the University of Michigan developed a mouse model that recapitulates many hallmarks of gut inflammation seen in people with Crohn’s disease.

Emily Hollister: ‘From microbiome to therapeutics and diagnostics’

The microbiome may be a source for biomarkers leading to therapeutic discoveries and diagnostics. We discuss it with Emily Hollister, Vice President of Diversigen.

How a beneficial gut microbe became a deadly pathogen

Researchers have figured out how specific strains of Enterococcus faecalis became a deadly pathogen, causing a series of deadly infections in the mid 1980s.

Common bacteria could influence wound healing

Researchers have found that several strains of bacteria, including the pathogen Staphylococcus aureus, can influence the healing of diabetic foot ulcers.

Richard Ellis: ‘Bringing probiotics from the lab to the market’

Richard Ellis, Head of Business Development at Biose, explains how CDMO companies assist start-ups in bringing live biotherapeutic products to the market.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top